ArticleFrontiers in immunology2023

Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab.

Yun-Tzu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.